Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA022388-001

ACUVUE THERAVISION WITH KETOTIFEN(KETOTIFEN FUMARATE)

Manufacturer: JOHNSON JOHNSON VISN

FDA Approval: 25/02/2022

Route: OPHTHALMIC · DRUG-ELUTING CONTACT LENS

Active Ingredients

KETOTIFEN FUMARATE EQ 19MCG BASE

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ACUVUE THERAVISION WITH KETOTIFEN — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.